I’m not exactly sure how the time has passed so quickly, but somehow it’s already September and we can officially say that the Colfax Marathon Weekend is next month!
Our 3rd Annual Running for Nana team has already grown to 21 people! I cannot wait to join you in support of Achieving Cures Together and the fight to end C. difficile on October 16th and 17th.
If you would like to join our team, I would absolutely LOVE to have you. And, there’s no time like the present! By September 13th, if we have just 8 more Saturday runners (Half Marathon, Marathon/Relay, or 10-mile) or 16 5K runners – or a combination thereof – we will once again have a Charity Partner tent in Charity Village on Race Weekend (picture below from our 2019 team)! All of the details on how to sign up are in the previous blog post, linked here.
Also, I completely understand if running isn’t your thing. If you still want to “Run for Nana” and fight against C. diff, we are raising funds again this year to directly support Achieving Cures Together and their fight against C. diff and other awful conditions.
As many of you know, since 2016, we’ve partnered with ACT and Dr. Khoruts from the University of Minnesota’s Microbiota Therapeutics Program (MTP) – two of the leaders in C. difficile research. Because of the generosity of each of you through philanthropic support, we’ve raised ~$93,000 in the fight to end C. difficile since Running for Nana started! This year, our goal is to pass the $100,000 mark. If you would like to help us reach this goal, please visit the ACT Fundraising Page Link: https://www.achievingcures.com/colfaxmarathon.
To date, these donations have significantly helped to advance the fight against C. difficile:
- Over 800 patients with recurrent C. diff that could not be cured with standard antibiotics have been successfully treated (98% success rate) at the University of MN through the intestinal microbiota transplantation (IMT) procedure – all at no cost to the patient.
- The MTP developed capsules of the IMT treatment, making it more accessible to fight recurrent C. diff.
- The team has increased their ability to provide the capsules for critical clinical trials. All therapeutic microbiota is manufactured in accordance with pharmaceutical protocols.
- There are five active research trials utilizing the treatment including the MATCH Trial, which is a multi-center, placebo-controlled study at the VA. This is the largest study of its kind. The team continues to explore uses for the treatment beyond C. diff, and the other active trials are for patients with advanced liver disease, autism, ulcerative colitis, and intensive chemotherapy.
This progress would not have been possible without each of you, and I cannot thank you enough for being a part of these advancements! Nana would be thrilled to know that fewer people have had to suffer the awful effects of C. difficile.
Sending you all a great big hug – I hope to see you in October!